When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
presented by
presented by
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
At ViVE 2024, Panelists Share Prior Authorization Progress and Frustration in Payer Insights Program
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Leslie Orne, CEO of Trinity Life Sciences
In this month's episode, we dive into some recent executive appointments occurring in the healthcare world, as well as layoffs affecting the industry. We also hear from Leslie Orne, who recently became the new CEO of Trinity Life Sciences, which provides consulting services and technology solutions to life sciences firms looking to commercialize their product.
presented by
Canada and the Midwest in Life Sciences, 75 Years in the Making
The Consulate General of Canada in Chicago is currently celebrating the 75th anniversary of its diplomatic presence in the Midwest.
How L&D in Regulated Industries Can Move Beyond Just Compliance to Impact
The Covid-19 pandemic has forced life sciences companies to take a fresh look at how they do business. But as they reinvent their operations, companies often overlook a critical function: Their learning and development programs.
Creating an Omnichannel Customer Journey in Healthcare
Improving Customer Experience and Conversion in Healthcare & Life Sciences.
The Impact Brands: Empowering Wellness Through Natural and Holistic Solutions
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.
How health tech can improve the patient and provider experience
Leaders in healthcare draw attention to the myriad ways cloud computing technology is transforming healthcare.
How health tech can improve the patient and provider experience
Leaders in healthcare draw attention to the myriad ways cloud computing technology is transforming healthcare.
H1 acquires Faculty Opinions to grow its global expert network
Faculty Opinions brings together the comments and opinions of thousands of top researchers in life sciences and medicine. Combined with H1's extensive intel on healthcare providers, the acquisition expands H1's reach and opportunity to impact healthcare by bringing this data under one umbrella, H1 CEO Ariel Katz said.
The future of regulatory labeling compliance depends on technology adoption
The life sciences industry is more quickly adapting to new methods, standards and requirements. The focus is now on how to drive greater data governance and quality through a unified framework. The challenge comes in instituting a framework that will meet regulatory and labeling requirements.
Unlocking Transparency in PBM Pricing
The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.
Cerner to snap up Kantar’s health division for $375M
The EHR giant is planning to buy Kantar Health, which provides data, analytics and research to the life sciences industry. Through the acquisition, Cerner aims to provide its clients with more access to data analytics and research expertise and engagement with life sciences companies.
Healthcare execs going all-in on AI, survey shows
The survey, conducted by Optum, shows that healthcare executives' confidence in AI is high, and most expect to soon see cost savings from implementing the technology. Further, a majority are looking to hire talent with experience developing AI.
How life sciences companies are re-engaging with customers in the COVID-19 era
Did you miss the webinar? Register now and hear the best practices and new perspectives to help re-engage with your customers during the coronavirus pandemic.
J.P. Morgan on the state of life sciences and strategies to fuel innovation
In an interview, Peter Meath, J.P. Morgan’s co-head of Healthcare and Life Sciences, Middle Market Banking & Specialized Industries, says the Covid-19 pandemic has cast a bright light on the life sciences industry with startups raising venture funding at record levels as the virus has transformed the way people usually do business in the sector.
Section 32 targets $350 million for third fund
The VC firm, started by the former heads of Foundation Medicine and Google Ventures, is raising $350 million for its third fund, according to a filing with the Securities and Exchange Commission.